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Abbreviations 
ARDS: acute respiratory distress syndrome 
AQP: aquaporin 
CMOS: complementary metal-oxide-semiconductor 
DMSO: dimethyl sulfoxide 
EDTA: ethylenediaminetetraacetic acid  
fMLF: n-formylmethionine-leucyl-phenylalanine 
GM-CSF: granulocyte-macrophage colony-stimulating factor 
IL: interleukin 
LDG: low density granulocyte 
LPS: lipopolysaccharide 
Na+/H+: sodium-ion proton 
NADPH: nicotinamide adenine dinucleotide phosphate  
NETs: neutrophil extracellular traps 
PAF: platelet activating factor 
PBS: phosphate-buffered saline 
PDMS: polydimethylsiloxane 
PMN: polymorphonuclear leukocytes 
ROCK: rho-associated coiled-coil containing protein kinase 
ROS: reactive oxygen species 
RT-DC: real-time deformability cytometry 
TNF: tumor necrosis factor-α  
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Abstract 
It has become increasingly apparent that the biomechanical properties of neutrophils impact 
on their trafficking through the circulation and in particularly through the pulmonary capillary 
bed. The retention of polarized or shape-changed neutrophils in the lungs was recently proposed 
to contribute to ARDS pathogenesis. Accordingly, this study tested the hypothesis that neutrophil 
priming is coupled to morpho-rheological changes capable of altering cell function. We employ 
real-time deformability cytometry (RT-DC), a recently developed, rapid and sensitive way to 
assess the distribution of size, shape, and deformability of thousands of cells within seconds. 
During RT-DC analysis, neutrophils can be easily identified within anticoagulated ‘whole blood’ 
due to their unique granularity and size, thus avoiding the need for further isolation techniques, 
which affect biomechanical cell properties. Hence RT-DC is uniquely suited to describe the 
kinetics of morpho-rheological cell changes. We reveal that, following activation or priming, 
neutrophils undergo a short period of cell shrinking and stiffening, followed by a phase of cell 
expansion and softening. In some contexts, neutrophils ultimately recover their un-primed 
mechanical phenotype. The mechanism(s) underlying changes in human neutrophil size are 
shown to be Na+/H+ anti-port-dependent and are predicted to have profound implications for 
neutrophil movement through the vascular system in health and disease. 
 
Introduction 
As the first responders to infection, neutrophils require highly tuned functional flexibility. The 
ability to change functional status in response to immune-modulators allows the neutrophil to 
patrol the body in a relatively quiescent state while remaining capable of sensing and then 
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employing appropriate responses when threats arise [1]. When quiescent, or un-primed 
neutrophils are exposed to certain pro-inflammatory cytokines or chemokines (e.g. TNF, fMLF, 
PAF, GM-CSF) they transition into a primed state. Neutrophil priming is characterized by the 
generation of reactive oxygen species, and some enhanced immune functions including NET 
formation and chemotaxis [2]. This primed state enhances their response to a subsequent 
exposure to an activating stimulus [2, 3]. Although neutrophil priming was originally discovered 
in vitro [4], it has been reported in a number of in vivo settings including systemic infection [5]. 
Neutrophil priming delays apoptosis, increasing the time viable cells spend at sites of 
inflammation or tissue injury [6-8]. Following a second exposure to stimuli, primed neutrophils 
become maximally activated, producing increased superoxide anions and employing a range of 
effector functions including phagocytosis, degranulation of antibacterial proteins, and release of 
NETs [9]. 
In addition to the described functional and biochemical changes, neutrophils undergoing 
activation exhibit morpho-rheological changes to their biophysical shape. It has been reported 
that activated neutrophils are smaller and stiffer than their un-activated and un-primed 
counterparts [10-13], although there exist conflicting reports of neutrophils expanding post-
stimulation [14].  Travel into and through the microcapillary system is essential for neutrophil 
migration to sites of infection or damage. Narrow capillary constrictions (5 µm) force 
neutrophils to deform in order to pass through [15]. Hence, changes in neutrophil shape, size and 
stiffness all drastically influence neutrophil travel through such capillary beds. As neutrophils 
become primed and subsequently activated, they take on a progressively polarized and amoeboid 
shape. Primed neutrophils have also been reported to be much stiffer than resting neutrophils [12, 
13], a process that might be useful for the tethering and rolling process neutrophils undergo 
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within blood vessels prior to extravasation into surrounding tissues in response to a stimulatory 
agent [16]. 
Of note, the lung pulmonary microvasculature, which takes the entire cardiac output 
approximately once per minute, consists of a particularly extensive and narrow capillary network 
[17]. Although the small, bi-concave, non-nucleated red blood cells can move through the 
pulmonary microvasculature with ease, and seemingly also un-primed neutrophils, stiffer primed 
leukocytes exhibit markedly delayed transit through the human lungs [17]. This is particularly 
interesting in the context of lung diseases such as ARDS where high levels of neutrophil priming 
in the circulation leads to increased neutrophil entrapment in the pulmonary microcirculation 
[18, 19].  However, we have shown that the trapping of these primed neutrophils in the lungs is 
surprisingly transient. One potential explanation for how primed neutrophils exit from the 
pulmonary vasculature has been the proposal that these cells can recover i.e. actively de-prime in 
the pulmonary capillary [19, 20]. 
Although several mechanisms of neutrophil de-priming have been advanced, this process 
remains poorly understood. Firstly, neutrophils appear to spontaneously de-prime if they do not 
receive on-going or repeated stimulation [21, 22]. Secondly, we have shown that neutrophils can 
be mechanically de-primed.  Hence, Ekpenyong et. al. reported that as primed and shape-
changed neutrophils are directed through a ‘microfluidic microcirculation mimetic’ (MMM) 
made up of channels with lung capillary-sized constrictions, or in separate experiments 
repeatedly stretched with optical lasers, both processes recovered the neutrophils back very 
rapidly to a smoother, softer state. These neutrophils were subsequently capable of swiftly 
exiting the MMM [15]. Thirdly glucocorticoids and catecholamines have been reported to 
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increase neutrophil deformability and reduce pseudopod formation [23]. This leads to neutrophil 
release from the microcapillary networks (particularly those associated with intravascular 
marginated pools) and back into the freely circulating blood pool. These drugs may, in fact, de-
prime neutrophils, thereby reducing the retention of neutrophils in the capillaries of patients with 
inflammatory disorders [23, 24]. Of interest, TNF and IL-1β also stiffen leukocytes, possibly 
leading to increased margination and endothelial interactions consistent with the inflammation 
associated with these cytokines [25]. Given the importance of morpho-rheological properties to 
neutrophil entrapment and migration within the vasculature, it is likely that such changes also 
impact on leukocyte dysfunction in disease. 
With the advent of RT-DC, we are now in a position to track and define in more detail the 
changes in the morphological and biomechanical properties of neutrophils during priming and 
de-priming. RT-DC is a recently developed, morpho-rheological phenotyping technique in which 
measurement and analysis of cell deformability is performed in real-time and the number of cells 
analyzed is theoretically limitless [26]. As cells flow through a microfluidic channel constriction 
in a viscous carrier solution, pressure gradients and shear stresses act to deform these cells. A 
high-speed camera then captures images of each cell as it transits through the microfluidic 
channel, and the cell contour is identified and analyzed in real-time. Accordingly, cell size, 
deformation, and surface smoothness can be quickly and easily quantified continuously at 
measurement rates of up to 1000 cells/sec to create an RT-DC profile of morpho-rheological cell 
parameters [26-28]. Calculation of Young’s modulus decouples the independent measures of size 
and deformation within a constriction channel, allowing an inherent material property, cell 
stiffness to be determined [29]. Cell image brightness combined with area data are sufficient for 
identification of erythrocytes, lymphocytes, monocytes, neutrophils, eosinophils, and basophils 
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within a human ‘whole blood’ sample, allowing for simultaneous morpho-rheological 
characterization of all major immune cell types [30]. Only a few microliters of blood are 
necessary to generate such RT-DC profiles, and the findings can be independently validated in 
isolated cell populations [30]. In short, RT-DC provides a fast and accurate method to analyze 
cellular size, deformation, and shape with a combination of speed, ease, and completeness not 
previously available. 
Here we report on the morphological and mechanical effects of neutrophil priming and post-
priming characteristics under whole-blood relevant conditions using RT-DC. We describe a 
novel biphasic change in cell size in response to priming, which triggers a rapid (and previously 
recognized) contractile phase, but also a later volumetric expansion with neutrophils swelling by 
approximately 18% over their original size. After initial stiffening, the latter expansion phase 
involves additional neutrophil softening. We present evidence that the Na+/H+ antiporter is 
mechanistically involved in this neutrophil expansion and speculate that this process may occur 
in parallel with neutrophil de-priming (Graphical Abstract).  
Materials & Methods 
Blood: All studies complied with the Declaration of Helsinki and involved written informed 
consent from all participants. Ethical permission for taking peripheral blood was obtained from 
the Cambridge Local Research Ethics Committee (REC reference 06/Q0108/281) and from the 
ethics committee of the Technische Universität Dresden (EK89032013, EK458102015). 
Peripheral blood was collected using a 20-gauge butterfly needle into a 1.8 mL sodium citrate S-
monovette (Sarstedt) using vacuum aspiration. For blood volumes over 9 mL, blood was drawn 
into a 40 mL syringe and transferred to 50 mL Falcon polypropylene tubes (BD) with 4 mL 3.8% 
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sodium citrate (Martindale Pharmaceuticals). For indicated supplementary experiments, blood 
was drawn into a 1.6 mL K3EDTA S-monovette (Sarstedt). 
Neutrophil purification: For each neutrophil isolation, cells were purified from sodium-citrated 
peripheral venous human blood samples. For purification, a two Percoll discontinuous gradient 
was used as described previously [31]. In brief, erythrocytes and leukocytes were separated by 
sedimentation with 6% dextran. Platelets were then removed from autologous plasma via 
centrifugation and the leukocyte-rich layer re-suspended in platelet-poor autologous plasma and 
under-layered by discontinuous (42% and 51%) plasma-Percoll gradients (Thermo Fisher 
Scientific). Following centrifugation, granulocytes were removed from the 42%/51% interface 
and washed. Counting was performed using a haemocytometer. Cytospin slides were prepared 
for each neutrophil isolation, and cell purity was assessed by light microscopy. Neutrophils 
prepared in this manner were routinely 95% neutrophils, with the major contaminating cells 
being eosinophils. 
Real-time deformability cytometry: RT-DC was performed as described previously [26, 28]. 
In brief, neutrophils were re-suspended by gentle mixing in CellCarrier buffer (Zellmechanik 
Dresden GmbH) at concentrations of up to 2.5x107 cells/mL.  CellCarrier is based on 1xPBS 
buffer containing 0.5% methylcellulose. Cell suspensions were drawn into 1 mL syringes and 
placed in a syringe pump (neMESYS, Cetoni GmbH) of the AcCellerator (Zellmechanik 
Dresden GmbH), an extension for an inverted microscope. Syringes were connected to polymer 
tubing, which was attached to the sample inlet of a Flic20 PDMS microfluidic chip 
(Zellmechanik Dresden GmbH). The chip contains reservoirs that are connected by a square 
measurement channel with a 20x20 µm2 cross-section. Another syringe without cells was filled 
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with CellCarrier buffer, placed in the syringe pump, and connected to the sheath inlet of the 
microfluidic chip. RT-DC measurements were collected at a cellular flow rate of 0.12 µL/s (0.03 
µL/s sample flow and 0.09 µL/s sheath flow). For isolated cell populations, an open gating 
strategy was employed. For whole blood measurements, 50 µL blood was diluted into 950 µL 
CellCarrier buffer and a gate for cells sized 5-16 µm parallel to and 5-20 µm perpendicular to 
flow direction was applied. This was sufficient to exclude single erythrocytes and erythrocyte 
doublets. An inverted microscope in combination with a high-speed CMOS camera (Mikrotron 
GmbH) captured images of cells at a frame rate of 2000 frames/s as they reached the end of the 
constriction channel. The experiments presented in this manuscript were conducted using two 
RT-DC setups located at different sites (United Kingdom and Germany), which we believe 
increases data credibility. Real-time image analysis was performed during the measurement 
process and data files necessary for single cell morpho-rheological (MORE) analysis (see below) 
exported for all detected cells.  
Morpho-rheological (MORE) analysis: Previous reports have already described methods to 
analyze RT-DC data files [28, 30]. In brief, a cell tracing algorithm implemented in C/LabVIEW, 
in combination with off-line analysis using ShapeOut software and custom-written Python 
scripts allow for generation of a neutrophil ‘morpho-rheological’ profile. For each cell detected, 
data describing a bright field image of the cell, the contour of the cell, and the cell size (as the 
cross-sectional area of the cell) was exported and analyzed. Cell size was obtained from the area 
inside the convex hull, a processed contour, where all points contributing to concave curvature 
were removed. Deformation is a measure of the cell’s deviation from sphericity and is calculated 
from the convex hull of the cell:  
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where A is the convex hull area and l is the length of the convex hull perimeter. Pre-existing 
shape deviations from sphericity were controlled for by analyzing cells within a reservoir devoid 
of stresses in front of the constriction channel. In this manner, cellular deformation due to 
constriction stresses alone was obtained and presented. The ratio of convex hull area to cell 
contour area is defined as the cellular area ratio and provides a measure of cell surface 
roughness. Cells with area ratios in the range of 1.0-1.05 were used to compare leukocyte 
deformation and size. The mean brightness of the cell was determined using all pixel values 
falling within the cell’s contour.  Major leukocyte sub-populations were identified based on cell 
size and mean brightness. Red blood cells can be easily identified due to their extremely 
deformable state within the constriction channel. For this study, we studied just human 
neutrophils. Importantly, pixel brightness can be influenced by factors including the image focus 
and thickness of the microfluidic chip. This is not an issue when distinguishing between 
populations of cells measured at the same time, through the same microfluidic chip. For further 
detailed information see Toepfner et al. [30].   
Neutrophil activation: fMLF (0.1 µM), PAF (1 µM), LPS (1 µg/mL), or GM-CSF (0.1 µg/mL) 
were used to prime neutrophils for the times indicated. During incubation samples were kept in 2 
mL tubes (Eppendorf) at 37˚C within a ThermoMixer C (Eppendorf) set at 450 rpm. 
Experiments were initiated within 1 h of blood drawing. 
Inhibitors: Prior to priming, neutrophils were treated with amiloride (10 µM), AQP-9 blocking 
antibody (100 µg/mL, InsightBio) for 15 min, or the ROCK inhibitor Y-27632 (1-10 µM) for 15 
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min prior to priming. For indicated experiments, 125 mM isotonic choline chloride was used as 
sodium-free buffer instead of PBS. DMSO or PBS served as vehicle controls. 
AQP-9 expression: Neutrophils were isolated as detailed above at 5x106/mL in IMDM 
containing 1% autologous serum. Priming was undertaken using 1 µM PAF, 100 nM fMLF, 20 
ng/mL TNF or 10 ng/mL GM-CSF for 30 min, except PAF, to which neutrophils were exposed 
for 5 min. Time-matched control cell populations were also prepared. Cells were incubated in a 
heat block at 37 oC, 300 rpm. Cells were subsequently fixed using 400 µL ice-cold 1:40 CellFix. 
The cells were then incubated with 5 µl of FITC-Aqp9 antibody, or isotype control, for 30 min at 
4 oC in the dark and analyzed immediately using a LSR Fortessa® flow cytometer. 
Macropinocytosis: Neutrophils isolated as above (5x106/mL in IMDM with 1% autologous 
serum) were treated with 1 µM amiloride, or vehicle control, for 30 min. Following this, they 
were incubated in the presence or absence of 100 nM fMLF, with 10 µg/mL of pHrodo Green 
10,000 Dextran for 5, 10, 15, 30, 60 or 120 min. Cells were subsequently fixed using 400 µL ice-
cold 1:40 CellFix. Cells were kept at 4 oC in the dark and then analyzed immediately on the LSR 
Fortessa®. 
Confocal microscopy: Neutrophils were prepared at 2x106/mL in Live Cell Imaging Solution 
containing 1% autologous serum and plated (180 µL of the above suspension) in 12-well, poly-
L-lysine-coated flat bottomed plate wells and treated with 1 µM of amiloride or vehicle control 
for 30 min at 37 oC under 5% CO2. Cells were subsequently treated with 100 nM fMLF, or 
vehicle control, in the presence of 10 µg/mL of pHrodo Green 10,000 Dextran 
(LifeTechnologies). Cells were concomitantly stained with 0.1% Hoechst 33342 and imaged 
using an SPE Leica® confocal microscope. Two lasers were used; the ultraviolet laser was used 
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to excite Hoechst 33342 with 15% laser power and 800 gain, and the blue laser to excite pHrodo 
green 10,000 Dextran with 25% laser power and 850 gain. Z-stacks of 5–10 µm were obtained, 
with a minimum of 3 random fields for each condition.  
Phase-contrast microscopy: Isolated neutrophils were suspended in HBSS/MOPS buffer at 
2x106/mL at room temperature. The buffer was prepared freshly each day using Hank’s balanced 
salt solution (GIBCO UK) with 10 mM 3-(N-morpholino) propane-sulfonic acid (MOPS). The 
pH was adjusted to 7.4 with 7.5% sodium hydrogen carbonate. After 30 min incubation with or 
without 10 nM fMLF at 37 oC, HBSS/MOPS buffer with 2.5% glutaraldehyde was added to fix 
the cells. Neutrophils were then washed twice in HBSS/MOPS buffer and examined via phase 
contrast microscopy using a 40x objective. 
Isoelasticity lines and Young’s moduli: From RT-DC data, apparent Young’s moduli can be 
calculated from cell size and deformation using numerical simulations [32] and theoretical 
models [29]. The effects of shear thinning of the CellCarrier buffer and deformation offset due to 
pixilation were accounted for as previously described [33]. Calculations of apparent Young’s 
moduli and isoelasticity lines assume cells can be approximated to purely elastic, homogenous 
isotropic spheres, just as the Hertz model extracts an apparent Young’s modulus for cells 
analyzed using atomic force microscopy enabled nanoindentation experiments. Analysis of 
Young’s modulus is included in RT-DC analysis software ShapeOut version 0.8.4 onwards.  
Statistics and Software: Statistics: Mean and SEM of median values derived from independent 
RT-DC trials were plotted and differences between experimental conditions assessed using 
repeated measures ANOVA with Bonferroni post-hoc testing using Graph Pad Prism version 5. 
One-way ANOVA, two-way ANOVA, paired and unpaired t-tests were used, as indicated in the 
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Figure legends. One, two, or three asterisks were awarded for significance levels P<0.05, P<0.01 
and P<0.001, respectively. ShapeOut is available as an open source application on GitHub 
[https://github.com/ZELLMECHANIK-DRESDEN/Shape-Out/releases; P. Müller et al., 2017].  
 
Results 
Neutrophils can be analyzed by RT-DC in whole blood immediately following blood drawing, 
eliminating the need for further cell purification (Figure 1A). As reported by Toepfner et al, 
brightness and area alone can be used to identify the major leukocytes in whole blood (Figure 
1B) [30]. Stiffness of the cell can be calculated from its size and deformation values (Figure 1C). 
The area ratio describes cellular shape. An area ratio of 1 indicates a perfectly smooth cell, with 
higher area ratios indicating rougher cells (Figure 1D). Area ratio allowed for the detection of 
neutrophil polarization after fMLF stimulation (Figure 1E). Although the morpho-rheological 
parameters of neutrophils vary little among healthy volunteers [30], different RT-DC setups give 
slightly different baseline values for neutrophils (Supplementary Figure 1). This baseline 
variation is due to small differences of the optics in even high quality microscopes, which may 
yield slightly different absolute values. Supplementary Figure 1A shows a systematic deviation 
of about six percent in PMN size between the two setups. This is due to the accuracy of the 
length scale determination of an individual microscope - i.e. the length in object space that is 
projected to the size of a single pixel of the image. These are not random fluctuations; within a 
single setup, measurements are highly reproducible and the absolute values of the PMN size are 
valid within the limitation of accuracy for both setups. This might be comparable to differences 
in the absolute values of mean fluorescence intensity (MFI) that would be obtained if completing 
the same experiment on different flow cytometers. To suppress these purely technical, non-
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random deviations from the presentation of the data and because this paper focuses on neutrophil 
kinetics, we have displayed results in the main data set in terms of delta values i.e. the absolute 
difference between unstimulated and stimulated neutrophils from the same individual (e.g. 
Figure 1E). This allows, despite the mentioned baseline difference of different RT-DC setups, for 
clear graphical representation of a dynamic process with consistent kinetics across healthy blood 
donors. In the interest of full transparency, raw data are graphed in the supplementary figure set. 
Experiments were carefully controlled to include comparison of neutrophils at time zero to 
unstimulated neutrophils that were time-matched to autologous stimulated counterparts. These 
data demonstrated no impact of time on unstimulated neutrophil size, deformation, or area ratio 
within the time frames analyzed and are shown in Supplementary Figure 1. 
First, we looked at the morpho-rheological kinetics of neutrophils following stimulation with 
fMLF. Fascinatingly, we found that neutrophil size contracts within seconds, only to expand 
after 15 minutes, for up to three hours (Figure 2A). This biphasic process of neutrophil 
contraction followed by expansion was consistent across a variety of neutrophil priming agents, 
including PAF, LPS and GM-CSF. Although the kinetics in response to different priming agents 
varied slightly, the distinct phases of neutrophil contraction followed by expansion were stable 
and consistent (Figure 2B, 2C). Cell by cell analysis of stimulated blood samples and 
visualization by locally weighted scatterplot smoothing (Lowess trend line) for neutrophils of 
each blood donor revealed that neutrophil size remains constant during RT-DC blood 
measurements, even if requiring up to fifteen minutes to perform (Figures 2D and 2E). The 
suspension of blood in CellCarrier buffer halted the post-priming kinetic process of the 
neutrophils. Accordingly, measurements depict neutrophil state at the time the blood was placed 
in CellCarrier buffer. In addition to the noted changes in neutrophil size, we observed a dramatic 
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increase in area ratio within 1 minute of stimulation with fMLF (Figure 2F). Neutrophil 
polarization was visually confirmed with phase-contrast microscopy (Supplementary Figure 2A). 
We observed that neutrophils had begun to enter the expansion phase by 15 minutes after 
priming. To assess the density of these expansion-phase neutrophils, we placed unstimulated and 
fMLF-primed neutrophils on a density gradient (Supplementary Figure 2B, C). Neutrophils 
primed for 20 minutes with fMLF were less dense than their unstimulated counterparts, with 
approximately 80% isolating with the lymphocytes- and monocytes-rich Percoll layer compared 
to less than 5% with unstimulated neutrophils (Supplementary Figure 2D). RT-DC analysis 
further revealed that fMLF-treated neutrophils placed on the density gradient were larger than 
unstimulated controls (Supplementary Figure 2E) by the same magnitude observed in the 
previous experiments assessing the post-priming kinetics (Figure 2A and 2B). The alignment of 
these independent approaches supports our characterization of post-primed, expansion phase 
neutrophils. 
The deformation of neutrophils exposed to fMLF (Figure 3A) or other stimuli (Figure 
3B) was assessed by similarly comparing time-matched, stimulated and unstimulated blood 
neutrophils. Time without stimulation had no impact on neutrophil deformation (Supplementary 
Figure 1B). However, post stimulation deformation trends (Figure 3A and 3B) followed 
remarkably similar kinetics to the changes in neutrophil size (Figure 2A and 2B). Deformation is 
determined by both cell size and cell stiffness, so we wondered whether cell size kinetics fully 
explained this phenomenon, or whether changes in cell stiffness might also contribute. 
Accordingly, we calculated the Young’s moduli for this dataset, and report that at the early (1 
minute) time-point after fMLF, neutrophils in addition to being smaller were also significantly 
stiffer (Figure 3C). Neutrophils became significantly softer during the post-priming expansion 
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phase. By 45 minutes after stimulation, neutrophils had recovered to stiffness parameters similar 
to those of unstimulated neutrophils (Figure 3C). 
Since rapid neutrophil stiffening, due to the increased thickness and contractility of the 
actomyosin cortex, is a hallmark of neutrophil activation, we used Y-27623, which does not 
affect neutrophil viability but specifically inhibits ROCK [34] to successfully reduce the 
magnitude of cell stiffening that occurs after priming with fMLF (Figure 3D, 3E). Inhibition of 
ROCK partially blocked contraction in cell size, yet seemingly had no impact on later cell 
expansion (Figure 4A). Conversely, blocking the Na+/H+ anti-porter with the macropinocytosis 
inhibitor amiloride completely impeded the expansion phase (Figure 4B). Amiloride alone had 
no impact on unstimulated neutrophils within the time frames analyzed (Supplementary Figure 
3). Choline chloride had a similar inhibitory effect on neutrophil expansion (Figure 4C).  
While neutrophil take-up of 10,000 MW dextran was evident even under basal unstimulated 
conditions, priming induced a clear increase in the uptake of dextran consistent with the timeline 
observed for increases in cell size. Treatment with amiloride prevented dextran uptake, as 
demonstrated by confocal microscopy and flow cytometry of isolated neutrophils (Figure 4D, 
4E). We confirmed the presence of AQP-9 on neutrophils using flow cytometry (Figure 4F) and 
demonstrated that following treatment of isolated neutrophils with an AQP-9 blocking antibody, 
no priming-induced expansion occurred (Figure 4G). Although different isolation processes 
induce size and deformation changes to neutrophils (Supplementary Figure 4), the kinetics of the 
response to priming were consistent between whole blood neutrophils and Percoll-isolated 
neutrophils (Supplementary Figure 5). The reported post-priming kinetics occur in the presence 
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and absence of exogenous calcium, as shown by analysis of blood samples prepared with EDTA 
(Supplementary Figure 6). 
Discussion 
Here we present a novel observation describing the series of morpho-rheological changes that 
occur in neutrophils following exposure to priming agents and demonstrate an overlap of the 
morphological and functional properties of neutrophils. It has been reported that polarization and 
reorganization of the actin cytoskeleton increase with neutrophil migration, facilitating invasion 
at inflammatory sites and the clearance of pathogens [14, 35, 36]. We speculate that the morpho-
rheological changes seen in neutrophils may allow for neutrophils to be freed from entrapment 
within microvasculature [18]. By area ratio kinetics we demonstrate that neutrophils are capable 
of re-circularizing from their heavily polarized, primed state, and do so with a clear increase in 
their overall cell size and deformation.  
RT-DC provides an analysis of morpho-rheological neutrophil properties in a contact-free 
environment. In the microvasculature primed neutrophils are entrapped within capillaries and in 
direct contact with endothelial cells. However, the advantage of RT-DC is that it allows analysis 
of many thousands of neutrophils within whole blood immediately after blood drawing i.e. with 
minimal sample manipulation. Through the use of the RT-DC, we have been able to study in 
detail and in real-time the events occurring in human neutrophils after exposure to priming 
agents. This is not currently possible using in vivo techniques [15]. 
We demonstrate that within the expansion phase, neutrophils are softer. Theoretically, a 
smaller and more pliable neutrophil would be most effective at maneuvering through the tiny 
constrictions in the pulmonary or tissue microvasculature. For this study, we used calculations 
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based on Young’s modulus to decouple the relative contributions of size and stiffness for 
neutrophil deformability [29]. For the range of values associated with the reported kinetics of 
post-priming, simple free energy comparisons demonstrate that a reduction in stiffness 
contributes most strongly to a cell’s ability to pass through narrow constrictions. Accordingly, in 
the context of neutrophil-relevant size and stiffness values, a larger, softer sphere deforms more 
than a smaller, stiffer sphere. Specifically, expansion phase neutrophils are advected through a 5 
µm constriction more easily because of their reduced stiffness, despite their increased diameter. 
The increased actomyosin cortex occurring during the initial priming-induced contraction phase 
resists shape changes due to the enhanced surface tension, despite these cells’ decreased size. 
Subsequent volume increases ameliorates the contractility of the cortex, facilitating easier shape 
changes to accommodate passage through small constrictions. 
Macropinocytosis is an actin-dependent, clathrin-independent form of endocytosis, in which 
surface membrane ruffles non-selectively fold extracellular material into endocytic vacuoles 
called macropinosomes, which are subsequently engulfed into the cell [37]. Macropinocytosis is 
particularly important for antigen presentation by macrophages and dendritic cells [37], and 
although the literature on neutrophil macropinocytosis is not extensive [38, 39], the process has 
been linked to neutrophil migration [40]. Macropinocytosis also plays a role in tumor metastasis 
[41]. Amiloride inhibits the Na+/H+ antiporter, and selectively inhibits macropinocytosis 
without affecting other types of endocytosis [42-44]. We demonstrate that amiloride blocks post-
priming neutrophil expansion completely, and further show through dextran uptake assays [45, 
46] that primed neutrophils undergo macropinocytosis on a timeline consistent with the observed 
kinetics of neutrophil expansion. As no extracellular sodium ions are available, isotonic choline 
chloride similarly prevents Na+/H+ antiporter function, and also blocks the post-priming 
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expansion phase. These results indicate neutrophils are not expanding due to water uptake alone, 
e.g. if a rough neutrophil expanded its contained volume and took on a smooth phenotype.  
Rather, bulk plasma membrane is added during this kinetic process through fusion of secretory 
vesicles. 
Antiport-mediated transport of Na+ into cells also drives subsequent influx of water [47]. 
Hence we considered whether water uptake via aquaporins, in addition to non-specific 
extracellular uptake via macropinocytosis, might contribute to the expansion phase. Both 
macropinocytosis and water influx are blocked by inhibition of Na+/H+ exchange [43, 47]. In 
patients with systemic inflammatory response syndrome, neutrophils have increased AQP-9 
expression [48] and blocking AQP-9 has been shown to reduce neutrophil activation-induced 
shape changes [49], and hence is the most widely researched neutrophil aquaporin [50, 51]. We 
focused our efforts accordingly and demonstrated an ablation of post-priming expansion in 
neutrophils treated with an AQP-9 blocking antibody. Autologous stimulated neutrophils did not 
expand sufficiently to ascertain whether this contribution was significant, but these data suggest 
AQP-9 may contribute to post-priming cell expansion. Recent and unpublished data from the 
Chilvers’ group indicate that neutrophils additionally express AQP-1 and AQP-6 in the plasma-
membrane, which may play a similar role to AQP9. (Subburayalu J and Pocock J, unpublished). 
Accordingly, further research is necessary to determine the role of the aquaporins in neutrophil 
priming. 
It was recently shown that patients with viral respiratory tract infections or acute respiratory 
distress syndrome have larger, more deformed neutrophils in their blood [30]. Neutrophil 
swelling has also been reported in the context of severe trauma [52], although activated 
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neutrophils are canonically thought to be stiffer [10-13]. We propose this apparent discrepancy 
may be traced back to the time course demonstrated here. Neutrophils contract immediately 
following priming, and yet become larger, softer, and less dense as they begin to recover from 
the priming process. Consequently, in patient blood we may observe only the larger, softer cells 
rather than the smaller, stiffer early primed cells, which are apt to get trapped in the pulmonary 
microcirculation. Accumulation of primed or activated neutrophils within the lung 
microvasculature and interstitial components is a hallmark of ARDS, and thought to be 
responsible for local injury associated with this disease [53].  
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Figure 1 RT-DC measurement of whole blood.   
A Structure of the microfluidic RT-DC chip. Single blood cells during whole blood measurement are 
visible. Magnification of a round shaped neutrophil surrounded by red blood cells (RBC) in the inlet (upper 
right) and a deformed RBC and a neutrophil in the channel (lower left). B Nucleated blood cell (NBC) 
populations differentiated by area and brightness. NBC with representative images, platelets and 
microRBC < 25 µm2 (black dots, images not shown). C Deformation and E modulus of blood 
neutrophils. Comparison of neutrophil deformation between channel and inlet by paired t-test (n = 8). D 
RT-DC parameters for morphological neutrophil characterisation. Exemplary images of neutrophils 
with different area ratios (AR), smooth shaped (AR 1.0) to highly ruffled (AR 1.15). E fMLF stimulation of 
whole blood. Mean and SEM of neutrophil AR over time, changes referenced against unstimulated, time-
matched controls, compared by repeated measures ANOVA and Bonferroni post-test (t0 to t30; n = 8). 
Figure 2 Size of neutrophils during priming and post-priming upon blood stimulation. 
A, B Size change of stimulated blood neutrophils over time. Time courses of blood neutrophil size 
after stimulation of whole blood with fMLF (A) and overview of neutrophil size kinetics after blood 
stimulation with different agonists (B, fMLF (black diamond), PAF (red diamond), GM-CSF (green square) 
and LPS (blue square). Mean and SEM of stimulated blood neutrophil size changes, shown in reference 
against unstimulated, time-matched controls. Differences between samples and controls by repeated 
measures ANOVA and Bonferroni post-test (t0 to t45; n = 8). C Exemplary images of blood neutrophils 
after fMLF stimulation of blood. Size (and deformation) changes shown at different time points. Length 
is measured in pixel, scale bar (10 µm) shown. D, E Blood neutrophil size analysis on single cell 
level. Size of the first 200 measured blood neutrophils of n = 5 blood donors after one minute (t1, D) and 
15 minutes (t15, E) of fMLF blood stimulation with Lowess trendline for the neutrophils of each donor. F 
Area ratio of neutrophils changes in fMLF activated blood samples over time. Data shown as mean 
and SEM, differences between samples by repeated measures ANOVA and Bonferroni post-test (n = 8). 
Increase of area ratio coincides with size changes at t1 and t15 (Fig. 2A).  
Figure 3 Mechanics of neutrophil priming and post-priming upon blood stimulation. 
A, B Deformation change of stimulated blood neutrophils over time. Time courses of blood 
neutrophil deformation after stimulation of whole blood with fMLF (A) and overview of neutrophil 
deformation kinetics after blood stimulation with different agonists (B, fMLF (black diamond), PAF (red 
diamond), GM-CSF (green square) and LPS (blue square). Deformation change of stimulated blood 
neutrophils referenced against unstimulated, time-matched controls, data shown as mean and SEM. 
Differences between samples and controls by repeated measures ANOVA and Bonferroni post-test (t0 to 
t45; n = 8). C Quantification of deformability (E modulus). Blood neutrophils compared to controls at 
different time points after fMLF stimulation by one-way ANOVA and Bonferroni post-test (n ≥ 3). D 
Exemplary images of purified neutrophils after inhibition of fMLF induced deformation change by 
Y-27623. Neutrophil deformation after preincubation with 1 µM (Y1) and 10 µM (Y10) Y-27623 at one 
minute (t1) after fMLF stimulation. Scale bar (10 µm) shown. E Quantification of the inhibitory Y-27623 
effect on purified neutrophils. Neutrophil E modulus after preincubation with 1 µM (Y1) and 10 µM (Y10) 
Y-27623 after fMLF stimulation for one minute (t1) and 15 minutes (t15) compared to unstimulated, time-
matched controls by one-way ANOVA and Bonferroni post-test (n ≥ 4). 
Figure 4 fMLF-mediated neutrophil size expansion is Na+/H+ antiport dependent. 
A Influence of Y-27623 on the size of neutrophils. Purified neutrophils after one minute (t1) and 15 
minutes (t15) of fMLF stimulation compared to non-stimulated controls by one-way ANOVA and Bonferroni 
post-test (n ≥ 4). All stimulation and control measurements after preincubation with 1 µM (Y1), 10 µM (Y10) 
Y-27623 or PBS respectively. B Inhibitory effect of amiloride on neutrophil expansion. Size kinetics 
of fMLF stimulated purified neutrophils with and without amiloride pre-treatment, samples shown as mean 
and SEM, referenced against unstimulated, time-matched controls. Differences between treatments by 
two-way ANOVA (p < 0.05; n = 3). C Inhibitory effect of choline chloride on neutrophil expansion. 
Size kinetics of fMLF stimulated purified neutrophils in isotonic, alkali cation-free medium compared to 
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PBS controls, samples shown as mean and SEM referenced against unstimulated, time-matched 
controls. Differences between treatments by two-way ANOVA (p < 0.05; n = 5) D Amiloride-mediated 
inhibition of dextran uptake. Exemplary confocal images of purified neutrophils 15 minutes post fMLF 
stimulation with and without amiloride pre-treatment. Green fluorescence indicates dextran uptake. E 
Quantification of neutrophil dextran uptake. Mean fluorescence intensity (MFI) of dextran in purified 
neutrophils 5 minutes (dots) and 15 minutes (squares) post fMLF stimulation, compared to fMLF 
stimulated neutrophils pretreated with amiloride by Kruskal-Wallis test with a Dunn’s post-test for multiple 
comparisons (n = 3). F Aquaporin 9 expression of stimulated neutrophils quantified by MFI. 
Influence of fMLF, PAF, GM-CSF and TNF on AQP9 expression compared to unstimulated control (n = 
3). G Aquaporin 9 antibody (AQP9 ab) effect on neutrophil expansion. Neutrophil size change post 
fMLF stimulation over time with and without AQP9 antibody pre-treatment, mean and SEM shown in 
reference against unstimulated, time-matched controls (n = 3). 
 
 
Supplementary figure 1 RT-DC raw data and setup comparison. 
A – D Kinetics of fMLF stimulated blood neutrophils measured by two different RT-DC setups, RT-
DC setup 1 (dashed line; n = 3) with RT-DC setup 2 (continuous line; n = 5). Mean and SEM shown for 
blood neutrophils size (A), deformation (B), area ratio (C) and standard deviation of brightness (D) 
comparing fMLF stimulated blood (black diamond) to unstimulated, time-matched controls (white 
diamond).  
Supplementary figure 2 Shape, density and size changes of neutrophils after fMLF stimulation. 
A Phase contrast microscopy of neutrophils. Shape changes at 15 minutes (t15) after fMLF stimulation 
in comparison to time-matched control. B RT-DC analysis of upper band cells obtained by separation of 
blood with discontinuous Percoll gradients. Identification of neutrophils by brightness and area following 
stimulation of blood with fMLF, compared to controls. C, D Density distribution of neutrophils 
following isolation from blood via Percoll gradient. Upper and lower bands shown in green (C). 
Change in neutrophil distribution between upper (upBand) and lower (lowBand) band after 15 minutes (t15) of 
fMLF stimulation (D). Difference by unpaired t-test (n = 5).  E Size of neutrophils from autologous 
donors, isolated with or without 15 minutes of fMLF blood stimulation. Differences between samples 
by paired t-test (n = 5). 
Supplementary figure 3 Control data (amiloride and aquaporin 9) to Figure 4.   
A Influence of DMSO and amiloride on neutrophil size. Neutrophil size after 30 minutes (pre-
treatment) and 115 minutes (experiment time) of exposure to amiloride or DMSO. Mean and SEM shown 
(n = 3). B Aquaporin 9 expression of fMLF stimulated neutrophils and unstimulated neutrophils 
compared to isotype controls. Purified neutrophils were stained with FITC-labeled aquaporin 9 antibody or 
isotype control mAb (n=3). 
Supplementary figure 4 Characterisation of neutrophils in blood and post isolation. 
A – D Comparison of neutrophils in blood 5 minutes (t5) post blood draw to neutrophils in blood 
15 minutes (t15) post blood draw, neutrophils derived from Percoll gradient directly after 
separation (t5) and after rest (t15) and compared to neutrophils derived from blood at t15 after RBC 
lysis. Total values of mean and SEM shown for size (A), deformation (B), area ratio (C) and E modulus 
(D). Differences of samples by 1-way ANOVA and Bonferroni post-test (n ≥ 3). 
Supplementary figure 5 Effect of fMLF on purified neutrophils. 
A – C Assessment of short interval, post-priming kinetics by continuous RT-DC measurements of 
fMLF-stimulated purified neutrophils (measurement 1 to measurement 10; fMLFM1-M10) over 30 minutes 
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compared to unstimulated controls at t0 (ControlM1-M3) and t30 (ControlM4-M6). Following 90 minutes of fMLF 
stimulation (fMLFM11-M13) neutrophils were again compared to unstimulated, time-matched controls 
(ControlM7-ControlM9). RT-DC measurements were collected in quick succession and are graphed from 
left to right in the order by which they were taken. Total values of mean and SEM are shown for size (A), 
deformation (B) and area ratio (C; n = 3). 
Supplementary figure 6 Neutrophil response to fMLF in blood with and without exogenous 
calcium. 
A – C Kinetics of neutrophil size (A), deformation (B) and area ratio (C) in fMLF stimulated K3EDTA 
blood (dashed line) compared to Na3Citrate blood (continuous line). Mean and SEM of neutrophil 
size over time, changes referenced against unstimulated, time-matched controls (n ≥ 3). 
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